Clinical Trials Logo

Ischemic Heart Disease clinical trials

View clinical trials related to Ischemic Heart Disease.

Filter by:

NCT ID: NCT03040947 Recruiting - Hypertension Clinical Trials

MRI Sequence and Imaging Protocol Development

BikeMRI
Start date: March 2016
Phase:
Study type: Observational

The purpose of this study is to develop imaging protocols when using cardiovascular magnetic resonance (CMR) to assess cardiac functions, morphology and tissue characterization. The National Heart Research Institute Singapore (NHRIS) houses two dedicated CMR scanners to support the numerous investigator initiated projects in patients with various cardiac pathologists. By optimizing novel CMR sequences used in these studies, scanning time can be shortened for patients with underlying cardiac diseases.

NCT ID: NCT03030495 Active, not recruiting - Clinical trials for Ischemic Heart Disease

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

IMPACT-FFR
Start date: December 2016
Phase:
Study type: Observational [Patient Registry]

1. To compare the risk of atherosclerotic lesion progression and subsequent patient-oriented composite outcomes (all-cause mortality, any MI, or any Ischemia-driven repeat revascularization) between deferred lesions with or without over microvascular disease, defined as physiological classification 2. To explore independent predictors of atherosclerotic lesion progression in deferred lesions based on fractional flow reserve-guided strategy and treated by contemporary medical treatment

NCT ID: NCT02992431 Active, not recruiting - Hypertension Clinical Trials

Participatory Patient Care Planning in Primary Care

4PHC
Start date: January 2017
Phase: N/A
Study type: Interventional

In the aging population, the prevalence of chronic diseases and multimorbidity has become common. Therefore, the planning and coordination of care have become more important. However, it is not known what kind of treatment plan should be and what kind of patients would benefit most of it. This research focuses on the participatory patient care planning in primary health care. In general, the participatory patient care planning (PPCP) aims to engage patients in self-care, to improve the collaboration between patients and professionals and to improve the use of resources. The present study investigates the feasibility and effectiveness of the PPCP. The specific research questions of the present study are: Does the PPCP have an impact on the patient's quality of life? Does the PPCP improve the quality of care in management of chronic diseases? Does the PPCP improve patient's commitment with self-care? Does the PPCP impact on the use of health care services? The data consists of people aged at least 18 years living in the municipality of Siilinjärvi with diabetes, coronary heart disease or hypertension and who are recorded in in Siilinjärvi Health Care Center electronic patient record. The participating patients are recruited from those who contacts SiiIinjärvi Health Care Center in order to have a follow-up visit because of the treatment of their disease. This study aims to recruit 700 patients. The participants are allocated into the intervention group and into the control group receiving usual care. Intervention consists of the PPCP. This includes the patient activation questionnaire form, a visit to the nurse who conducts the measurements (blood pressure, waist measurement, weight and length) and a visit to the general practitioner who discusses and agrees with the patient about the treatment goals and follow-up resulting in the written PPCP. The main out-come measures are the quality of health related life measured with the 15D; the level of patient's activity in self-care with the Patient Activation Measurement (PAM); life satisfaction, self-rated health, a reduction in productivity with the Work Productivity and Activity Impairment Questionnaire (WPAI: GH), and the disease specific measures (blood pressure, HbA1C, LDL-cholesterol, body mass index and waist measurement). In addition, pain intensity and interference (NRS 0-10), mood (BDI-21), the number of visits and phone calls and referrals are measured.

NCT ID: NCT02986295 Recruiting - Clinical trials for Ischemic Heart Disease

Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

SMARTDESK-MX
Start date: April 1, 2016
Phase: N/A
Study type: Observational [Patient Registry]

Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent

NCT ID: NCT02984371 Recruiting - Atrial Fibrillation Clinical Trials

Epicardial Fat Pads Ablation During Coronary Surgery

Start date: June 2016
Phase: Phase 2
Study type: Interventional

The aim of this prospective randomized study was to assess the efficacy of ablation of the ganglionated plexi localized in the epicardial fat pads for preventing recurrences of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation undergoing coronary artery bypass grafting.

NCT ID: NCT02982434 Recruiting - Atrial Fibrillation Clinical Trials

The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation

Start date: September 2016
Phase: Phase 2
Study type: Interventional

The aim of this prospective randomized double-blind study was to compare the efficacy of new pharmaceutical composition containing botulinum toxin injection in epicardial fat pads for preventing recurrences of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation undergoing coronary artery bypass grafting.

NCT ID: NCT02968771 Active, not recruiting - Clinical trials for Ischemic Heart Disease

Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT

METS
Start date: November 2016
Phase:
Study type: Observational

The aim of this study is to analyze metabolomic pattern of patients after cardiac stress in order to detect differences based on the type of stress (physical or pharmacological with adenosine agonists) and result of test (positive or negative for ischemia) and to indentify biochemical markers with prognostic value. Clinical data of enrolled patients regarding demographics, cardiovascular risk factors, pretest probability and previous cardiovascular disease will be recorded. Follow up will be at one, three and five years and will be performed by clinical recordings or phone call when necessary. Blood samples of patients undergoing myocardial perfusion SPECT (Single Photon Emission Computed Tomography) are taken before, immediately after stress and 2h after stress. Serum samples will be analyzed by nuclear magnetic resonance in order to know metabolomic profile.

NCT ID: NCT02943616 Withdrawn - Clinical trials for Ischemic Heart Disease

ABSORB Post-Approval Clinical Study

Start date: August 2017
Phase: N/A
Study type: Interventional

The ABSORB Post-Approval Clinical Study is a prospective, open-label, multi-center, single-arm, non-randomized trial to evaluate the safety of the use of ABSORB in a real-world setting following commercial physician training'and to observe the effectiveness of commercial physician training on appropriate vessel sizing.

NCT ID: NCT02942628 Completed - Clinical trials for Ischemic Heart Disease

Vegetarian Diet in Patients With Ischemic Heart Disease

VERDI
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Open label, 4 week randomized, cross-over study to compare the effect of a vegetarian diet to a conventional (meat containing) diet based on the Swedish average meat consumption on a range of parameters with prognostic importance for cardiovascular disease.The study will be conducted in patients diagnosed with ischemic heart disease. We hypothesize that patients will benefit from a vegetarian diet as assessed by multiple risk markers for this type of disease with a primary focus on changes in oxidized LDL cholesterol.

NCT ID: NCT02941380 Completed - Clinical trials for Ischemic Heart Disease

Exploration of Cerebral Pathophysiology During and After CABG Using CPB

Start date: July 2011
Phase: N/A
Study type: Observational

Purpose: The purpose of this study is to examine cerebral oxidative and inflammatory stress and cerebral hemodynamics during and after coronary artery bypass grafting and correlate with postoperative cognitive function.